GlassScriptPhysician profile
Edifel N Macatuno
NPI 1649219585
$853.94
in general payments reported to CMS, 2019-2025
16 companies · $210 in 2025
The $210 reported for 2025 was more than what 75% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $14.02 · 2021: $26.77 · 2022: $79.58 · 2023: $342 · 2024: $72.06 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $183.22 | 2022-2025 | |
| Cranial Technologies, INC | $116.33 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $102.77 | 2023-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $92.36 | 2019-2025 | Rotarix, Bexsero, Pediarix |
| Sanofi Pasteur INC. | $63.18 | 2019-2023 | |
| Sobi, INC | $61.46 | 2020-2023 | |
| Chiesi USA, INC. | $54.14 | 2025 | Curosurf |
| Ironshore Pharmaceuticals INC. | $33.71 | 2023-2024 | Jornay Pm |
| Genzyme Corporation | $24.55 | 2025 | |
| Nestle Healthcare Nutrition INC. | $24.06 | 2023 | |
| Biofire Diagnostics, LLC | $23.07 | 2019 | |
| Supernus Pharmaceuticals, INC. | $18.75 | 2024 | Qelbree |
| Sanofi-Aventis U.S. LLC | $16.86 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.06 | 2019 | |
| Genentech USA, INC. | $12.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edifel Macatuno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.